v3 Template
N

NewVale Capital

Life Sciences / Investment ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$167.0M
Funding Rounds
1
Last Funding
2024-05-13

About NewVale Capital

NewVale Capital is a growth equity investment firm focused on investing in proven, revenue-generating life science services businesses to bring the next generation of medicines to patients.

Products & Services

Growth Equity Investments:Invests in established life science services businesses with proven revenue streams.

Specialties

Growth Equity Investments Life Science Services

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Growth Equity Fund
T: -
FT: Growth Equity Fund 		A: 167000000
MR: -
FA: $167 million
FAN: 167000000 		D: 2024-05-13
FD: 2024-05-13 		5 investors
Growth Equity Fund Latest
2024-05-13
$167.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Todd Holmes

MANAGING PARTNER

LinkedIn (Pro only)
P

Patrick Lee

EXECUTIVE PARTNER

LinkedIn (Pro only)
R

Rich Fante

EXECUTIVE PARTNER

LinkedIn (Pro only)
S

Sami Hawwa

PRINCIPAL

M

Melanie Larkins

PRINCIPAL

A

Abigail Pohl Pierce

VICE PRESIDENT

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

NewVale Capital Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Investment
Company Size
~220 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro